Equities research analysts expect athenahealth, Inc (NASDAQ:ATHN) to post earnings per share of $0.92 for the current quarter, according to Zacks. Twenty Two analysts have made estimates for athenahealth’s earnings, with the lowest EPS estimate coming in at $0.82 and the highest estimate coming in at $1.11. athenahealth reported earnings per share of $0.51 in the same quarter last year, which indicates a positive year over year growth rate of 80.4%. The company is expected to issue its next quarterly earnings results on Thursday, July 19th.
On average, analysts expect that athenahealth will report full year earnings of $4.01 per share for the current fiscal year, with EPS estimates ranging from $3.67 to $4.56. For the next financial year, analysts anticipate that the business will report earnings of $4.63 per share, with EPS estimates ranging from $4.10 to $5.68. Zacks’ EPS averages are an average based on a survey of research analysts that cover athenahealth.
athenahealth (NASDAQ:ATHN) last released its earnings results on Thursday, April 26th. The health services provider reported $1.25 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.72 by $0.53. The firm had revenue of $329.40 million for the quarter, compared to analyst estimates of $318.13 million. athenahealth had a return on equity of 13.01% and a net margin of 6.77%. athenahealth’s revenue was up 15.4% compared to the same quarter last year. During the same period in the previous year, the company earned $0.32 earnings per share.
ATHN has been the topic of a number of research analyst reports. ValuEngine lowered athenahealth from a “hold” rating to a “sell” rating in a report on Friday, April 27th. Bank of America initiated coverage on athenahealth in a report on Tuesday, February 27th. They set a “neutral” rating and a $147.00 target price on the stock. Citigroup lowered their target price on athenahealth from $148.00 to $140.00 and set a “neutral” rating on the stock in a report on Monday, April 30th. Royal Bank of Canada set a $136.00 target price on athenahealth and gave the stock a “hold” rating in a report on Monday, April 30th. Finally, Robert W. Baird lifted their target price on athenahealth to $150.00 and gave the stock an “outperform” rating in a report on Tuesday, May 8th. One analyst has rated the stock with a sell rating, seventeen have assigned a hold rating and eight have assigned a buy rating to the company’s stock. athenahealth has a consensus rating of “Hold” and a consensus price target of $154.81.
athenahealth opened at $159.79 on Tuesday, Marketbeat.com reports. The stock has a market cap of $6.40 billion, a P/E ratio of 101.78, a PEG ratio of 2.96 and a beta of 1.26. athenahealth has a 52-week low of $111.61 and a 52-week high of $163.94. The company has a current ratio of 2.71, a quick ratio of 2.71 and a debt-to-equity ratio of 0.25.
In other athenahealth news, SVP Jonathan D. Porter sold 422 shares of the firm’s stock in a transaction dated Monday, May 7th. The stock was sold at an average price of $153.30, for a total transaction of $64,692.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Jonathan Bush sold 25,000 shares of the firm’s stock in a transaction dated Monday, May 7th. The stock was sold at an average price of $155.00, for a total value of $3,875,000.00. The disclosure for this sale can be found here. Insiders have sold a total of 41,979 shares of company stock valued at $6,244,631 over the last 90 days. Corporate insiders own 2.90% of the company’s stock.
A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Redwood Investments LLC acquired a new stake in athenahealth during the 1st quarter worth about $788,000. Amalgamated Bank lifted its holdings in shares of athenahealth by 6.9% during the 1st quarter. Amalgamated Bank now owns 8,434 shares of the health services provider’s stock valued at $1,206,000 after buying an additional 542 shares during the last quarter. Summit Trail Advisors LLC lifted its holdings in shares of athenahealth by 13,481.3% during the 1st quarter. Summit Trail Advisors LLC now owns 103,218 shares of the health services provider’s stock valued at $103,000 after buying an additional 102,458 shares during the last quarter. Wesbanco Bank Inc. acquired a new stake in shares of athenahealth during the 1st quarter valued at about $1,339,000. Finally, Xact Kapitalforvaltning AB lifted its holdings in shares of athenahealth by 47.1% during the 1st quarter. Xact Kapitalforvaltning AB now owns 5,937 shares of the health services provider’s stock valued at $849,000 after buying an additional 1,900 shares during the last quarter.
athenahealth Company Profile
athenahealth, Inc, together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems. It offers athenaCollector, a network-enabled billing and practice management solution; athenaClinicals, an electronic health record for managing patient's clinical documentation; athenaCommunicator, an engagement and communication solution that provides an automated communication service between patients and provider practices for interactions outside the exam room; and athenaCoordinator for order transmission and care coordination services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.